256 related articles for article (PubMed ID: 7542845)
1. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
[TBL] [Abstract][Full Text] [Related]
3. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
[No Abstract] [Full Text] [Related]
4. [Latex test used for diagnosis of dysentery caused by Shigella sonnei].
Kałuzewski S; Jagielski M
Med Dosw Mikrobiol; 1991; 43(1-2):25-35. PubMed ID: 1784135
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
6. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110.
Rajavelu P; Das SD
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):95-102. PubMed ID: 15985228
[TBL] [Abstract][Full Text] [Related]
7. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
8. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.
Orr N; Robin G; Lowell G; Cohen D
J Clin Microbiol; 1992 Aug; 30(8):2165-8. PubMed ID: 1500527
[TBL] [Abstract][Full Text] [Related]
9. Relationship between humoral immune responses and oral temperature during human shigellosis.
Mackowiak PA; Wasserman SS; Levine MM
J Infect Dis; 1993 Jun; 167(6):1449-52. PubMed ID: 8501337
[TBL] [Abstract][Full Text] [Related]
10. Plasma cytokine response in mice with bacterial infection.
Abram M; Vu ković D; Wraber B; Dorić M
Mediators Inflamm; 2000; 9(5):229-34. PubMed ID: 11200363
[TBL] [Abstract][Full Text] [Related]
11. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
[TBL] [Abstract][Full Text] [Related]
12. [Comparative determination of lymphocyte functional activity and serum O-antibody titers in acute dysentery patients].
Bunin KV; Kosiakova NI
Klin Med (Mosk); 1984 Feb; 62(2):50-3. PubMed ID: 6200646
[No Abstract] [Full Text] [Related]
13. [Use of immunofluorescence method in the diagnosis and study of pathogenesis of acute dysentery].
Pogorel'skaia LV; Vul'fovich IuV; Plotnikova IuK
Sov Med; 1991; (6):84-6. PubMed ID: 1887317
[No Abstract] [Full Text] [Related]
14. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome.
Vindenes HA; Ulvestad E; Bjerknes R
Eur J Surg; 1998 Sep; 164(9):647-56. PubMed ID: 9728783
[TBL] [Abstract][Full Text] [Related]
15. Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.
Barnoy S; Baqar S; Kaminski RW; Collins T; Nemelka K; Hale TL; Ranallo RT; Venkatesan MM
Vaccine; 2011 Aug; 29(37):6371-8. PubMed ID: 21596086
[TBL] [Abstract][Full Text] [Related]
16. Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency.
Chapel H; Puel A; von Bernuth H; Picard C; Casanova JL
Clin Infect Dis; 2005 May; 40(9):1227-31. PubMed ID: 15825022
[TBL] [Abstract][Full Text] [Related]
17. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
Borisov VA; Frolov AF
Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
[No Abstract] [Full Text] [Related]
18. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
19. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin.
Sander B; Skansén-Saphir U; Damm O; Håkansson L; Andersson J; Andersson U
Immunology; 1995 Dec; 86(4):512-8. PubMed ID: 8567014
[TBL] [Abstract][Full Text] [Related]
20. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers.
Orr N; Katz DE; Atsmon J; Radu P; Yavzori M; Halperin T; Sela T; Kayouf R; Klein Z; Ambar R; Cohen D; Wolf MK; Venkatesan MM; Hale TL
Infect Immun; 2005 Dec; 73(12):8027-32. PubMed ID: 16299296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
